Bivariate random effects models for meta-analysis of comparative studies with binary outcomes: Methods for the absolute risk difference and relative risk

Statistical Methods in Medical Research

Volumn 21, Issue 6, 2012, Pages 621-633

  Chu, Haitao ^a   Nie, Lei ^b   Chen, Yong ^c   Huang, Yi ^d   Sun, Wei ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^e IL   (United States)

Author keywords

beta binomial distribution; bivariate generalised linear mixed models; bivariate random effects models; clustered binary data; meta analysis

Indexed keywords

ARTICLE; BETA BINOMIAL DISTRIBUTION; BIVARIATE RANDOM EFFECTS MODEL; COMPARATIVE STUDY; DRUG EFFICACY; DRUG SAFETY; META ANALYSIS (TOPIC); SAMPLE SIZE;

DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; RISK; THIAZOLIDINEDIONES;

EID: 84870014622     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280210393712     Document Type: Article

References (41)

1. Egger M, Smith GD, Altman DG Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group ; 2001:
2. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical-trials. Stat Med. 1991 ; 10 (11). 1665-1677
3. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 ; 19 (3). 251-253
4. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 ; 7 (3). 177-188
5. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007 ; 356 (24). 2457-2471
6. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004 ; 23: 1351-1375
7. Bradburn MJ, Deeks JJ, Berlin JA, Localio AR. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007 ; 26 (1). 53-77
8. Tian L, Cai T, Pfeffer MA, Piankov N, Cremieux PY, Wei LJ. Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction. Biostatistics. 2009 ; 10 (2). 275-281
9. Vandermeer B, Bialy L, Hooton N, et al. Meta-analyses of safety data: a comparison of exact versus asymptotic methods. Stat Methods Med Res. 2009 ; 18 (4). 421-432
10. Rucker G, Schwarzer G, Carpenter J, Olkin I. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med. 2009 ; 28 (5). 721-738
11. Tang JL. Weighting bias in meta-analysis of binary outcomes. J Clin Epidemiol. 2000 ; 53 (11). 1130-1136
12. Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol. 2006 ; 59 (12). 1331-1332
13. Riley R, Abrams K, Sutton A, Lambert P, Thompson J. Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol. 2007 ; 7 (1). 3-3
14. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JAC. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics. 2007 ; 8 (2). 239-251
15. Riley RD, Thompson JR, Abrams KR. An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics. 2008 ; 9 (1). 172-186
16. Chu H, Nie L, Cole SR, Poole C. Meta-analysis of diagnostic accuracy studies accounting for disease prevalence: alternative parameterizations and model selection. Stat Med. 2009 ; 28 (18). 2384-2399
17. Chu H, Chen S, Louis TA. Random effects models in a meta-analysis of the accuracy of two diagnostic tests without a gold standard. J Am Stat Assoc. 2009 ; 104: 512-523
18. Chu H, Guo H, Zhou Y. Bivariate random effects meta-analysis of diagnostic studies using generalized linear mixed models. Med Decis Making. 2010 ; 30 (4). 499-508
19. Riley RD, Abrams KR, Lambert PC, Sutton AJ, Thompson JR. An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes. Stat Med. 2007 ; 26 (1). 78-97
20. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med. 2010 ; 29: 1282-1297
21. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The Lancet. 2009 ; 373 (9677). 1773-1779
22. Lee MLT. Properties and applications of the Sarmanov family of bivariate distributions. Commun Stat Theory Methods. 1996 ; 25 (6). 1207-1222
23. Sarmanov OV. Generalized normal correlation and two dimensional frechet classes. Doklady Soviet Mathematics). 1966 ; 168: 596-599
24. Schwartz LM, Woloshin S, Welch HG. Misunderstandings about the effects of race and sex on physicians' referrals for cardiac catheterization. N Engl J Med. 1999 ; 341 (4). 279-283
25. Cummings P. Early exposure to marijuana and risk of later drug use. JAMA. 2003 ; 290 (3). 329-330
26. Kalilani L, Atashili J. Measuring additive interaction using odds ratios. Epidemiol Perspect Innovat. 2006 ; 3 (1). 5-5
27. Greenland S. Interpretation and choice of effect measures in epidemiologic analyses. Am J Epidemiol. 1987 ; 125 (5). 761-768
28. Greenland S, Robins JM, Pearl J. Confounding and collapsibility in causal inference. Stat Sci. 1999 ; 14 (1). 29-46
29. Brumback B, Berg A. On effect-measure modification: relationships among changes in the relative risk, odds ratio, and risk difference. Stat Med. 2008 ; 27 (18). 3453-3465
30. McCullagh P. Sampling bias and logistic models. J Roy Stat Soc B Stat Meth. 2008 ; 70: 643-664
31. Longford NT, Diggle PJ, Nelder J, et al. Sampling bias and logistic models-discussion. J Roy Stat Soc B Stat Meth. 2008 ; 70: 664-677
32. Zeger SL, Liang KY, Albert PS. Models for longitudinal data-a generalized estimating equation approach. Biometrics. 1988 ; 44 (4). 1049-1060
33. Pinheiro JC, Bates DM. Approximations to the log-likelihood function in the nonlinear mixed-effects model. J Comput Graph Stat. 1995 ; 4 (1). 12-35
34. Burnham KP, Anderson DR Model selection and inference: a practical information-theoretic approach. New York: Springer-Verlag ; 1998:
35. Shuster JJ, Jones LS, Salmon DA. Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death. Stat Med. 2007 ; 26 (24). 4375-4385
36. Shuster JJ, Jones LS, Salmon DA. Rebuttal to Carpenter et al. comments on 'fixed vs. random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death'-reply. Stat Med. 2008 ; 27 (19). 3912-3914
37. Carpenter J, Rucker G, Schwarzer G. Comments on 'fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death'. Stat Med. 2008 ; 27 (19). 3910-3912
38. Waksman J, Kollar C. Comments on 'Rebuttal to Carpenter et al. 'comments on 'fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death'. Stat Med. 2009 ; 28 (3). 534-536
39. Dahabreh IJ. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone. Clin Trials. 2008 ; 5 (2). 116-120
40. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med. 2002 ; 21 (11). 1601-1623
41. Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med. 1995 ; 14 (24). 2685-2699